Kadmon Competitors and Similar CompaniesClear all
G1 Therapeutics's competitors and similar companies include Reata Pharmaceuticals.
 G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases. | |
Founding Date | Founding Date 2008 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Durham, US HQ | Locations Plano, US HQ Irving, US Plano, US |
Employees | Employees 17015% increase | Employees 3217% decrease |
Valuation ($) | Valuation ($) 377.2 m | Valuation ($) 6.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $2.2m (FY, 2022) |
Net income | Net income ($48m) (FY, 2023) | Net income ($311.9m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 289.6m | Total funding raised $ 468.9m |
For sources of this data, please see the company profile
View Company Profiles
Reata Pharmaceuticals
HQ
Plano, US
Employees
321↓ 7% decrease
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
View company